{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T17:16:12Z","timestamp":1789233372481,"version":"build-2803163510"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"crossref","award":["FRGS\/1\/2023\/STG01\/UITM\/02\/3"],"award-info":[{"award-number":["FRGS\/1\/2023\/STG01\/UITM\/02\/3"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02893-6","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T05:24:22Z","timestamp":1756445062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Aptamer as a therapeutic agent for dengue infections"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4411-8130","authenticated-orcid":false,"given":"Nur Aida Laili","family":"Mislan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5395-0040","authenticated-orcid":false,"given":"Citartan","family":"Marimuthu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6101-8923","authenticated-orcid":false,"given":"Amir Muhaimin","family":"Akmal Shukri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4788-2149","authenticated-orcid":false,"given":"Jeyanthi","family":"Suppiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5756-7660","authenticated-orcid":false,"given":"Rozainanee","family":"Mohd Zain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1268-2515","authenticated-orcid":false,"given":"Fadzilah","family":"Mohd Nor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3631-6504","authenticated-orcid":false,"given":"Seok Mui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"2893_CR1","unstructured":"Doggett SL. (2023) Dengue: A Crisis for Asia. FAOPMA Magazine, Federation of Asian and Oceania Pest Managers\u2019 Associations. pp 104\u2013110."},{"issue":"4 Suppl","key":"2893_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2149\/tmh.2011-S10","volume":"39","author":"S Kalayanarooj","year":"2011","unstructured":"Kalayanarooj S. Clinical manifestations and management of dengue\/dhf\/dss. Trop Med Health. 2011;39(4 Suppl):83\u20137. https:\/\/doi.org\/10.2149\/tmh.2011-S10.","journal-title":"Trop Med Health"},{"key":"2893_CR3","unstructured":"World Health Organization. Dengue: guidelines for diagnosis, treatment, prevention and control. World Health Organization; 2009."},{"key":"2893_CR4","doi-asserted-by":"crossref","unstructured":"Kaptein SJF, Goethals O,Kiemel D, Marchand A, Kesteleyn B, Bonfanti JF, Bardiot D, Stoops B, Jonckers THM, Dallmeier K, Geluykens P, Thys K, Crabbe M, Chatel-Chaix L, M\u00fcnster M, Querat G, Touret F, de Lamballerie X, Raboisson P, Simmen K, Chaltin P, Neyts J. A pan-serotype dengue virus inhibitor targeting theNS3\u2013NS4B interaction. Nature. 2021;598(7881):504\u20139.","DOI":"10.1038\/s41586-021-03990-6"},{"key":"2893_CR5","first-page":"711","volume":"159","author":"HA Rothan","year":"2014","unstructured":"Suputtamongkol Y, Khusmith S, Silachamroon U, Udomsangpetch R, Warachit B, Chokephaibulkit K, Phumratanaprapin W, Charunwatthana P, Looareesuwan S. Ivermectin accelerates circulating nonstructural protein 1 (NS1) clearance in adult dengue patients: a combined phase 2\/3 randomized double-blindedplacebo controlled trial. Clin Infect Dis. 2021;72(10):e586\u2013e593.","journal-title":"Antiviral Res"},{"key":"2893_CR6","doi-asserted-by":"crossref","unstructured":"Good SS, Westover JB, Jung KH, Zhou XJ, La Colla P, Collu G, Canard B, Sommadossi JP (2021) Evaluation of AT-752, a double prodrug of a guanosine nucleotide analog with in vitro and in vivo activity against dengue andother flaviviruses. Antimicrobial Agents and Chemotherapy 65(11):e00988-21.","DOI":"10.1128\/AAC.00988-21"},{"key":"2893_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.antiviral.2016.03.001","volume":"129","author":"KL Warfield","year":"2016","unstructured":"Rothan HA, Bahrani H, Mohamed Z, Teoh TC, Shankar EM, Rahman NA, Yusof R. Inhibitory effect of doxycycline against dengue virus replication in vitro. Antiviral Research. 2014;159:711\u201318.","journal-title":"Antiviral Res"},{"key":"2893_CR8","doi-asserted-by":"crossref","unstructured":"Chakraborty S, Chakravarti A, Roy P, Ghosh S, Ghosh S, Ghosh S. Investigation of the efficacy and safety of eltrombopag to correct thrombocytopenia in moderate to severe dengue patients\u2014a phase II randomized controlled clinical trial. IJID. 2020;29.","DOI":"10.1016\/j.eclinm.2020.100624"},{"issue":"8","key":"2893_CR9","first-page":"e0010636","volume":"16","author":"M Callahan","year":"2022","unstructured":"Warfield KL, Swenson DL, Olinger GG, Kalina WV, Aman MJ, Bavari S. Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4. Antiviral Res. 2016;129:93\u20138.","journal-title":"Antiviral Res"},{"issue":"11","key":"2893_CR10","doi-asserted-by":"publisher","first-page":"e1006673","DOI":"10.1371\/journal.ppat.1006673","volume":"13","author":"DR Glasner","year":"2017","unstructured":"Perry ST, Buck MD, Lada SM, Schindler C, Shresta S. An iminosugar withpotent inhibition of dengue virus infection in vivo. Antiviral Res. 2013;98(1):35\u201343.","journal-title":"PLoS Pathog"},{"issue":"2","key":"2893_CR11","doi-asserted-by":"publisher","first-page":"e0006209","DOI":"10.1371\/journal.pntd.0006209","volume":"12","author":"Y Budigi","year":"2018","unstructured":"Callahan M, Nagata LP, Buchanan TM, Lanteri MC, Kleinman SH, Busch MP. Randomized single oral dose phase 1 study of safety, tolerability, and pharmacokinetics of iminosugar UV-4 hydrochloride (UV-4B) in healthy subjects. Antiviral Res. 2022;16(8):e0010636.","journal-title":"PLoS Negl Trop Dis"},{"key":"2893_CR12","doi-asserted-by":"crossref","unstructured":"Glasner DR, Ratnasiri K, Puerta-Guardo H, Espinosa DA, Beatty PR, Harris E. Dengue virus NS1 cytokine-independent vascular leak is dependent on endothelial glycocalyx components. PLoS Pathogens. 2017;13(11):e1006673.","DOI":"10.1371\/journal.ppat.1006673"},{"key":"2893_CR13","doi-asserted-by":"crossref","unstructured":"Budigi Y, Ong EZ, Robinson LN, Ong LC, Rowley KJ, Winnett A, Tan HC, Hobbie S, Shriver Z, Babcock GJ, Alonso S, Ooi EE. Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein. PLoS Neglected Tropical Diseases. 2018;12(2):e0006209.","DOI":"10.1371\/journal.pntd.0006209"},{"key":"2893_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.antiviral.2017.05.007","volume":"144","author":"EZ Ong","year":"2017","unstructured":"Ong EZ, Budigi Y, Tan HC, Robinson LN, Rowley KJ, Hobbie S, Shriver Z, Babcock GJ, Alonso S, Ooi EE. Preclinical evaluation of VIS513, a therapeutic antibody against dengue virus, in non-human primates. Antiviral Res. 2017;144:44\u20137.","journal-title":"Antiviral Res"},{"issue":"8","key":"2893_CR15","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1086\/507635","volume":"43","author":"WK Wang","year":"2006","unstructured":"Wang WK, Chen HL, Yang CF, Hsieh SC, Juan CC,Chang SM, Yu CC, Lin LH, Huang JH, King CC. Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. Clin Infect Dis.2006;43(8):1023\u201330. https:\/\/doi.org\/10.1086\/507635","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2893_CR16","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1006\/viro.2002.1704","volume":"305","author":"WK Wang","year":"2003","unstructured":"Wang WK, Chao DY, Kao CL, Wu HC, Liu YC, Li CM, Lin SC, Ho ST,Huang JH, King CC. High levels of plasma dengue viral load during defervescence in patients withdengue hemorrhagic fever: implications for pathogenesis. Virol. 2003;305(2):330\u20138. https:\/\/doi.org\/10.1006\/viro.2002.1704","journal-title":"Virology"},{"issue":"6","key":"2893_CR17","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1086\/528805","volume":"197","author":"AO Guilarde","year":"2008","unstructured":"Guilarde AO, Turchi MD, Siqueira JB Jr, Feres VCR, Rocha B, Levi JE, Souza VAUF, Villas Boas LS, Pannuti CS, Martelli CMT. Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response. J Infect Dis. 2008;197(6):817\u201324. https:\/\/doi.org\/10.1086\/528805.","journal-title":"J Infect Dis"},{"issue":"1","key":"2893_CR18","doi-asserted-by":"publisher","first-page":"29201","DOI":"10.1038\/srep29201","volume":"6","author":"J Flipse","year":"2016","unstructured":"Flipse J, Wilschut J, Smit JM. Antibody-dependent enhancement of dengue virus infection in primary human macrophages; balancing higher fusion against antiviral responses. Sci Rep. 2016;6(1):29201. https:\/\/doi.org\/10.1038\/srep29201.","journal-title":"Sci Rep"},{"issue":"10","key":"2893_CR19","doi-asserted-by":"publisher","first-page":"e1011736","DOI":"10.1371\/journal.ppat.1011736","volume":"19","author":"A Teo","year":"2023","unstructured":"Teo A, Tan HD, Loy T, Chia PY, Chua CLL. Correction: Understanding antibody-dependent enhancement in dengue: are afucosylated IgG1s a concern? PLoS Pathog. 2023;19(10):e1011736. https:\/\/doi.org\/10.1371\/journal.ppat.1011736.","journal-title":"PLoS Pathog"},{"issue":"3","key":"2893_CR20","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1080\/15476286.2017.1414131","volume":"15","author":"J Bala","year":"2018","unstructured":"Bala J, Chinnapaiyan S, Dutta RK, Unwalla H. Aptamers in HIV research diagnosis and therapy. RNA Biol. 2018;15(3):327\u201337. https:\/\/doi.org\/10.1080\/15476286.2017.1414131.","journal-title":"RNA Biol"},{"issue":"4","key":"2893_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/biot.201100305","volume":"11","author":"S Kedzierski","year":"2012","unstructured":"Kedzierski S, Khoshnejad M, Caltagirone GTJ. Synthetic antibodies: the emerging field of aptamers. Biotechnol J. 2012;11(4):46\u20139. https:\/\/doi.org\/10.1002\/biot.201100305.","journal-title":"Biotechnol J"},{"issue":"9","key":"2893_CR22","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1093\/clinchem\/45.9.1628","volume":"45","author":"SD Jayasena","year":"1999","unstructured":"Jayasena SD. Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem. 1999;45(9):1628\u201350. https:\/\/doi.org\/10.1093\/clinchem\/45.9.1628.","journal-title":"Clin Chem"},{"issue":"11\u201312","key":"2893_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/prca.201200042","volume":"6","author":"V Thiviyanathan","year":"2012","unstructured":"Thiviyanathan V, Gorenstein DG. Aptamers and the next generation of diagnostic reagents. Proteom Clin Appl. 2012;6(11\u201312):563\u201373. https:\/\/doi.org\/10.1002\/prca.201200042.","journal-title":"Proteom Clin Appl"},{"key":"2893_CR24","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.bios.2014.09.010","volume":"64","author":"SY Toh","year":"2015","unstructured":"Toh SY, Citartan M, Gopinath SCB, Tang TH. Aptamers as a replacement for antibodies in enzyme-linked immunosorbent assay. Biosens Bioelectron. 2015;64:392\u2013403. https:\/\/doi.org\/10.1016\/j.bios.2014.09.010.","journal-title":"Biosens Bioelectron"},{"issue":"11","key":"2893_CR25","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S0165-9936(03)01204-1","volume":"22","author":"E Luzi","year":"2003","unstructured":"Luzi E, Minunni M, Tombelli S, Mascini M. New trends in affinity sensing: aptamers for ligand binding. Trends Anal Chem. 2003;22(11):810\u20138. https:\/\/doi.org\/10.1016\/S0165-9936(03)01204-1.","journal-title":"Trends Anal Chem"},{"key":"2893_CR26","doi-asserted-by":"publisher","unstructured":"Zhou H, Li Y, Wu W. Aptamers: promising reagents in biomedicine application. Adv Biology. 2024;2300584. https:\/\/doi.org\/10.1002\/adbi.202300584.","DOI":"10.1002\/adbi.202300584"},{"issue":"1","key":"2893_CR27","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.bios.2020.112312","volume":"9","author":"HY Li","year":"2020","unstructured":"Li HY, Wang Y, Tu J, Wang L, Kong DM. Advances in detection of infectious agents by aptamer-based technologies. Biosens Bioelectron. 2020;9(1):1671\u201381. https:\/\/doi.org\/10.1016\/j.bios.2020.112312.","journal-title":"Biosens Bioelectron"},{"key":"2893_CR28","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.bios.2019.112386","volume":"9","author":"M Vargas-Montes","year":"2019","unstructured":"Vargas-Montes M, Rojas-Anaya E, Rojas-Anaya B, Rojas-Anaya C. Enzyme-linked aptamer assay (ELAA) for detection of Toxoplasma ROP18 protein in human serum. Biosens Bioelectron. 2019;9:386. https:\/\/doi.org\/10.1016\/j.bios.2019.112386.","journal-title":"Biosens Bioelectron"},{"key":"2893_CR29","doi-asserted-by":"publisher","first-page":"199008","DOI":"10.1016\/j.talanta.2023.199008","volume":"323","author":"CM de Sousa Lacerda","year":"2023","unstructured":"de Sousa Lacerda CM, de Oliveira D, de Souza AA, de Oliveira JF, de Oliveira MDL. Foot-and-mouth disease virus: DNA aptamer selection for the 3ABC protein. Talanta. 2023;323:199008. https:\/\/doi.org\/10.1016\/j.talanta.2023.199008.","journal-title":"Talanta"},{"issue":"3","key":"2893_CR30","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1093\/nar\/gkab1277","volume":"50","author":"PR Gruenke","year":"2022","unstructured":"Gruenke PR, Liu J, Li J, Zhang Y, Wang Y, Zhang W, Zhang C, Zhang B. Selection and identification of an RNA aptamer that specifically binds the HIV-1 capsid lattice and inhibits viral replication. Nucleic Acids Res. 2022;50(3):1701\u201317. https:\/\/doi.org\/10.1093\/nar\/gkab1277.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2893_CR31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1021\/acsinfecdis.2c00456","volume":"7","author":"M Wang","year":"2023","unstructured":"Wang M, Zhang Y, Liu Y, Li X, Zhang Z, Wang J, Liu H, Zhang L. A universal aptamer for influenza A viruses: selection, recognition, and infection Inhibition. ACS Infect Dis. 2023;7(1):249\u201358. https:\/\/doi.org\/10.1021\/acsinfecdis.2c00456.","journal-title":"ACS Infect Dis"},{"issue":"4","key":"2893_CR32","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.tibtech.2022.10.008","volume":"41","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Juhas M, Kwok CK. Aptamers targeting SARS-COV-2: a promising tool to fight against COVID-19. Trends Biotechnol. 2023;41(4):528\u201344. https:\/\/doi.org\/10.1016\/j.tibtech.2022.10.008.","journal-title":"Trends Biotechnol"},{"issue":"52","key":"2893_CR33","doi-asserted-by":"publisher","first-page":"18902","DOI":"10.1073\/pnas.0507490102","volume":"102","author":"JH Lee","year":"2005","unstructured":"Lee JH, Canny MD, De Erkenez A, Krilleke D, Ng YS, Shima DT, Pardi A, Jucker F, Ferrara N, Popel AS. A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165. Proc Natl Acad Sci. 2005;102(52):18902\u20137. https:\/\/doi.org\/10.1073\/pnas.0507490102.","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"2893_CR34","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/cr.2015.20","volume":"25","author":"Z Hou","year":"2015","unstructured":"Hou Z, Weng J, Yao W, Nie J, Wang X, Liu Y, Wang Y, Liu J, Wang J, Wang Y. Characterization and target identification of a DNA aptamer that labels pluripotent stem cells. Cell Res. 2015;25(3):390\u20133. https:\/\/doi.org\/10.1038\/cr.2015.20.","journal-title":"Cell Res"},{"issue":"3","key":"2893_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1515\/bmt-2016-0136","volume":"5","author":"S Catuogno","year":"2017","unstructured":"Catuogno S, Esposito CL. Aptamer cell-based selection: overview and advances. Biomed Eng. 2017;5(3):49. https:\/\/doi.org\/10.1515\/bmt-2016-0136.","journal-title":"Biomed Eng"},{"issue":"4","key":"2893_CR36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.bioeng.2007.06.001","volume":"24","author":"R Stoltenburg","year":"2007","unstructured":"Stoltenburg R, Reinemann C, Strehlitz B. SELEX\u2014A (r)evolutionary method to generate high-affinity nucleic acid ligands. Biomol Eng. 2007;24(4):381\u2013403. https:\/\/doi.org\/10.1016\/j.bioeng.2007.06.001.","journal-title":"Biomol Eng"},{"issue":"12","key":"2893_CR37","doi-asserted-by":"publisher","first-page":"4522","DOI":"10.3390\/ijms21124522","volume":"21","author":"JP Elskens","year":"2020","unstructured":"Elskens JP, Elskens JM, Madder A. Chemical modification of aptamers for increased binding affinity in diagnostic applications: current status and future prospects. Int J Mol Sci. 2020;21(12):4522. https:\/\/doi.org\/10.3390\/ijms21124522.","journal-title":"Int J Mol Sci"},{"key":"2893_CR38","doi-asserted-by":"publisher","unstructured":"Thevendran R, Liew PS, Tan WS, Tan SC, Othman S, Yusof R. (2023) The diagnostic potential of RNA aptamers against the NS1 protein of dengue virus serotype 2. Diagnostics. 2023; 12(5):722. https:\/\/doi.org\/10.3390\/diagnostics12050722","DOI":"10.3390\/diagnostics12050722"},{"key":"2893_CR39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.talanta.2020.203210","volume":"1128","author":"H Wei","year":"2020","unstructured":"Wei H, Zhao Q, Zhong Y, Fan J, Zuo X, Xia F. Screening and application of a truncated aptamer for high-sensitive fluorescent detection of metronidazole. Talanta. 2020;1128:203\u201310. https:\/\/doi.org\/10.1016\/j.talanta.2020.203210.","journal-title":"Talanta"},{"key":"2893_CR40","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ab.2017.02.014","volume":"525","author":"HA Alhadrami","year":"2017","unstructured":"Alhadrami HA, Chinnappan R, Eissa S, Rahamn AA, Zourob M. High affinity truncated DNA aptamers for the development of fluorescence based progesterone biosensors. Anal Biochem. 2017;525:78\u201384. https:\/\/doi.org\/10.1016\/j.ab.2017.02.014.","journal-title":"Anal Biochem"},{"key":"2893_CR41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/978-981-15-5823-8_9","volume-title":"Immunodiagnostic technologies from laboratory to Point-Of-Care testing","author":"K Birader","year":"2020","unstructured":"Birader K, Keerthana LS, Yathirajarao T, Barla JA, Suman P. Methods for enhancing aptamer affinity for antigen detection and its characterization. In: Suman P, Chandra P, editors. Immunodiagnostic technologies from laboratory to Point-Of-Care testing. Singapore: Springer; 2020. pp. 163\u201383. https:\/\/doi.org\/10.1007\/978-981-15-5823-8_9."},{"issue":"4","key":"2893_CR42","first-page":"421","volume":"21","author":"H Hasegawa","year":"2016","unstructured":"Hasegawa H, Taira K, Sode K, Ikebukuro K. Methods for improving aptamer binding affinity. Biotechnol Lett. 2016;21(4):421.","journal-title":"Biotechnol Lett"},{"issue":"6","key":"2893_CR43","doi-asserted-by":"publisher","first-page":"e0131240","DOI":"10.1371\/journal.pone.0131240","volume":"10","author":"HL Chen","year":"2015","unstructured":"Chen HL, Hsu CW, Chan YL, Wu CJ, Chang HM, Lin CW. Selection and characterization of DNA aptamers targeting all four serotypes of dengue viruses. PLoS ONE. 2015;10(6):e0131240. https:\/\/doi.org\/10.1371\/journal.pone.0131240.","journal-title":"PLoS ONE"},{"key":"2893_CR44","doi-asserted-by":"crossref","unstructured":"Amano R, Takahashi M, Saito T, Tanaka T, Saito K, Takahashi H. (2024) A chimeric RNA consisting of SiRNA and aptamer for inhibiting dengue virus replication. NAR Mol Med. 2024; 1(4).","DOI":"10.1093\/narmme\/ugae025"},{"issue":"12","key":"2893_CR45","doi-asserted-by":"publisher","first-page":"7143","DOI":"10.1128\/JVI.77.12.7143-7149.2003","volume":"77","author":"CT Jones","year":"2003","unstructured":"Jones CT, Patkar CG, Kuhn RJ. Flavivirus capsid is a dimeric alpha-helical protein. J Virol. 2003;77(12):7143\u20139.","journal-title":"J Virol"},{"key":"2893_CR46","doi-asserted-by":"crossref","unstructured":"Ma L, Jones CT, Groesch TD, Kuhn RJ, Post CB. (2004) Solution structure of dengue virus capsid protein reveals another fold. Proc Natl Acad Sci. 2004;t101(10):3414\u20139.","DOI":"10.1073\/pnas.0305892101"},{"issue":"10","key":"2893_CR47","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1128\/JVI.75.10.4633-4640.2001","volume":"75","author":"AA Khromykh","year":"2001","unstructured":"Khromykh AA, Varnavski AN, Sedlak PL, Westaway EG. Coupling between replication and packaging of flavivirus RNA: evidence derived from the use of DNA-based full-length cDNA clones of Kunjin virus. J Virol. 2001;75(10):4633\u201340.","journal-title":"J Virol"},{"issue":"12","key":"2893_CR48","doi-asserted-by":"publisher","first-page":"6471","DOI":"10.1128\/JVI.02120-06","volume":"81","author":"CG Patkar","year":"2007","unstructured":"Patkar CG, Jones CT, Chang YH, Warrier R, Kuhn RJ. Functional requirements of the yellow fever virus capsid protein. J Virol. 2007;81(12):6471\u201381.","journal-title":"J Virol"},{"issue":"2","key":"2893_CR49","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1128\/JVI.05431-11","volume":"86","author":"MM Samsa","year":"2012","unstructured":"Samsa MM, Mondotte JA, Iglesias NG, Assun\u00e7\u00e3o-Miranda I, Barbosa-Lima G, Da Poian AT, Bozza PT, Gamarnik AV. Uncoupling cis-acting RNA elements from coding sequences revealed a requirement of the N-terminal region of dengue virus capsid protein in virus particle formation. J Virol. 2012;86(2):1046\u201358.","journal-title":"J Virol"},{"issue":"24","key":"2893_CR50","doi-asserted-by":"publisher","first-page":"13094","DOI":"10.1128\/JVI.00704-13","volume":"87","author":"CA Balinsky","year":"2013","unstructured":"Balinsky CA, Schmeisser H, Ganesan S, Singh K, Pierson TC, Zoon KC. Nucleolin interacts with the dengue virus capsid protein and plays a role in formation of infectious virus particles. J Virol. 2013;87(24):13094\u2013106.","journal-title":"J Virol"},{"issue":"5","key":"2893_CR51","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1099\/vir.0.83264-0","volume":"89","author":"S Sangiambut","year":"2008","unstructured":"Sangiambut S, Keelapang P, Aaskov J, Puttikhunt C, Kasinrerk W, Malasit P, Sittisombut N. Multiple regions in dengue virus capsid protein contribute to nuclear localization during virus infection. J Gen Virol. 2008;89(5):1254\u201364.","journal-title":"J Gen Virol"},{"issue":"2","key":"2893_CR52","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.tcb.2006.11.010","volume":"17","author":"F Mongelard","year":"2007","unstructured":"Mongelard F, Bouvet P. Nucleolin: a multifaceted protein. Trends Cell Biol. 2007;17(2):80\u20136.","journal-title":"Trends Cell Biol"},{"issue":"1","key":"2893_CR53","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s10637-013-0045-6","volume":"32","author":"JE Rosenberg","year":"2014","unstructured":"Rosenberg JE, Bambury RM, Van Allen EM, Drabkin HA, Lara PN, Harzstark AL, Wagle N, Figlin RA, Smith GW, Garraway LA, Choueiri TK. A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma. Investig New Drugs. 2014;32(1):178\u201387.","journal-title":"Investig New Drugs"},{"issue":"6972","key":"2893_CR54","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nature02165","volume":"427","author":"Y Modis","year":"2004","unstructured":"Modis Y, Ogata S, Clements D, Harrison SC. Structure of the dengue virus envelope protein after membrane fusion. Nature. 2004;427(6972):313\u20139.","journal-title":"Nature"},{"issue":"3","key":"2893_CR55","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.bbrc.2014.09.053","volume":"453","author":"SHA Gandham","year":"2014","unstructured":"Gandham SHA, Nomura N, Shirai H, Kobayashi N. Thioaptamers targeting dengue virus type-2 envelope protein domain III. Biochem Biophys Res Commun. 2014;453(3):309\u201315.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2893_CR56","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1006\/viro.1998.9200","volume":"246","author":"JT Roehrig","year":"1998","unstructured":"Roehrig JT, Bolin RA, Kelly RG. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus. Jamaica Virol. 1998;246(2):317\u201328.","journal-title":"Jamaica Virol"},{"key":"2893_CR57","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.ejmech.2016.10.007","volume":"125","author":"F Benmansour","year":"2017","unstructured":"Benmansour F, Trist I, Coutard B, Decroly E, Querat G, Brancale A, Barral K. Discovery of novel dengue virus NS5 methyltransferase non-nucleoside inhibitors by fragment-based drug design. Eur J Med Chem. 2017;125:865\u201380. https:\/\/doi.org\/10.1016\/j.ejmech.2016.10.007.","journal-title":"Eur J Med Chem"},{"key":"2893_CR58","first-page":"286","volume":"5","author":"L Liu","year":"2010","unstructured":"Liu L, Sun Y, Li Q, Xu Y, Ma J, Deng YQ, Yuan Z, Shi PY, Li XF. Flavivirus RNA cap methyltransferase: structure, function, and Inhibition. Antiviral Res. 2010;5:286\u2013303.","journal-title":"Antiviral Res"},{"key":"2893_CR59","first-page":"315","volume":"40","author":"JI Jung","year":"2018","unstructured":"Jung JI, Han SR, Lee SW. Development of RNA aptamer that inhibits methyltransferase activity of dengue virus. Biochem Lett. 2018;40:315\u201324.","journal-title":"Biochem Lett"},{"issue":"6","key":"2893_CR60","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/v9060137","volume":"9","author":"WC Ng","year":"2017","unstructured":"Ng WC, Soto-Acosta R, Bradrick SS, Garcia-Blanco MA, Ooi EE. The 5\u2032 and 3\u2032 untranslated regions of the flaviviral genome. Viruses. 2017;9(6):137.","journal-title":"Viruses"},{"issue":"2","key":"2893_CR61","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.virusres.2008.03.007","volume":"135","author":"RL Silva","year":"2008","unstructured":"Silva RL, Oliveira AS, Durigon EL, Oliveira DBL, Vasconcelos PF, Galler R, Ferreira PCP, Kroon EG, Bonjardim CA. Genetic analysis of dengue 3 virus subtype III 5\u2032 and 3\u2032 non-coding regions. Virus Res. 2008;135(2):320\u20135.","journal-title":"Virus Res"},{"issue":"6","key":"2893_CR62","doi-asserted-by":"publisher","first-page":"541","DOI":"10.4155\/fmc-2016-0233","volume":"9","author":"EJ Cnossen","year":"2017","unstructured":"Cnossen EJ, Dey AK, Schultes B, De La Fuente A, De La Fuente IM. Characterization of oligonucleotide aptamers targeting the 5\u2032-UTR from dengue virus. Future Med Chem. 2017;9(6):541\u201352.","journal-title":"Future Med Chem"},{"key":"2893_CR63","doi-asserted-by":"publisher","unstructured":"Santarpia G, Carnes E. Therapeutic applications of aptamers. Int J Mol Sci. 2024;25.https:\/\/doi.org\/10.3390\/ijms25126742","DOI":"10.3390\/ijms25126742"},{"key":"2893_CR64","doi-asserted-by":"publisher","unstructured":"Bege M, Ghanem Kattoub R, Borb\u00e1\u00e1s A. The 20th anniversary of Pegaptanib (MacugenTM), thefirst approved aptamer medicine: history, recent advances and future prospects of aptamers intherapy. Pharmaceutics. 2025;17Santarpia G, Carnes E. Therapeutic applications of aptamers. Int J Mol Sci. 2024;25. https:\/\/doi.org\/10.3390\/pharmaceutics17030394","DOI":"10.3390\/pharmaceutics17030394"},{"key":"2893_CR65","doi-asserted-by":"publisher","unstructured":"Fallah A, Imani Fooladi AA, Havaei SA, Mahboobi M, Sedighian H. Recent advances in aptamerdiscovery, modification and improving performance. Biochem Biophys Rep. 2024;40, 101852. https:\/\/doi.org\/10.1016\/j.bbrep.2024.101852","DOI":"10.1016\/j.bbrep.2024.101852"},{"key":"2893_CR66","doi-asserted-by":"publisher","unstructured":"Ni S, Zhuo Z, Pan Y, Yu Y, Li F, Liu J, Wang L,Wu X, Li D, Wan Y, Zhang L, Yang Z, Zhang BT, Lu A, Zhang G. Recent progress in aptamerdiscoveries and modifications for therapeutic applications. ACS Appl Mater Interfaces.2021;13(8):9500\u201319. https:\/\/doi.org\/10.1021\/acsami.0c05750","DOI":"10.1021\/acsami.0c05750"},{"issue":"1","key":"2893_CR67","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/anie.202318665","volume":"25","author":"A Bayani","year":"2025","unstructured":"Brown A, Brill J, Amini R,Nurmi C, Li Y. Development of better aptamers: Structured library approaches, selectionmethods, and chemical modifications. Angew Chem Int Ed. 2024;63(16), e202318665. https:\/\/doi.org\/10.1002\/anie.202318665","journal-title":"Clin Experimental Med"},{"key":"2893_CR68","doi-asserted-by":"publisher","unstructured":"Xia F, Duan Q, Zhang Q, Feng W, Ding D, Ji DK,Wang X, Tan W. Self-assembled aptamer nanoparticles for enhanced recognition and anticancertherapy through a lysosome-independent pathway. Acta Biomater. 2025;194:364\u201372. https:\/\/doi.org\/10.1016\/j.actbio.2024.12.015","DOI":"10.1016\/j.actbio.2024.12.015"},{"key":"2893_CR69","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3762\/bjnano.13.78","volume":"13","author":"NBF Almeida","year":"2022","unstructured":"Bayani A, Ghasemi F, Hashemi M, GanjalikhaniHakemi M, Ganjalikhani Hakemi M. Aptamer-based approaches in leukemia: a paradigm shift intargeted therapy. Clin Exp Med. 2025;25(1):186.","journal-title":"Beilstein J Nanotechnol"},{"key":"2893_CR70","doi-asserted-by":"crossref","unstructured":"Mahmoudian F, Hashemi M, GanjalikhaniHakemi M, Ghasemi F. Aptamers as an approach to targeted cancer therapy. Cancer Cell Int.2024;24(1):108.","DOI":"10.1186\/s12935-024-03295-4"},{"key":"2893_CR71","doi-asserted-by":"publisher","unstructured":"Ding D, Zhao H, Wei D, Yang Q, Yang C, Wang R, Chen Y, Li L, An S, Xia Q. Thefirst-in-human whole-body dynamic pharmacokinetics study of aptamer. Research. 2023;6:0126. https:\/\/doi.org\/10.34133\/research.0126","DOI":"10.34133\/research.0126"},{"issue":"1","key":"2893_CR72","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.synbio.2024.10.005","volume":"10","author":"AB Bl\u00e1zquez","year":"2025","unstructured":"Argondizzo APC, Silva D, Missailidis S. Applicationof aptamer-based assays to the diagnosis of arboviruses important for public health in Brazil. IntJ Mol Sci. 2020;22(1).","journal-title":"Synth Syst Biotechnol"},{"issue":"19","key":"2893_CR73","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.1039\/D4AN00812J","volume":"149","author":"AM Shukri","year":"2024","unstructured":"Almeida NBF, Silva J\u00fa\u00fanior AG, Silva J\u00fa\u00fanior AG, Oliveira MDL, OliveiraMDL, Oliveira MDL. DNA aptamer selection and construction of an aptasensor based ongraphene FETs for Zika virus NS1 protein detection. Beilstein J Nanotechnol. 2022;13:873\u201381.","journal-title":"Analyst"},{"issue":"7881","key":"2893_CR74","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41586-021-03990-6","volume":"598","author":"SJF Kaptein","year":"2021","unstructured":"Bl\u00e1\u00e1zquez AB, Jim\u00e9\u00e9nez de Oya N. Biosensors for the detection of flaviviruses: a review. SynthSyst Biotechnol. 2025;10(1):194\u2013206.","journal-title":"Nature"},{"issue":"5","key":"2893_CR75","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.1021\/acssensors.5c00263","volume":"10","author":"T Vairaperumal","year":"2025","unstructured":"Shukri AM, Rahman NA, Ahmad R, Ismail S, Yusof NA.In silico selection of aptamers against SARS-CoV-2. Analyst. 2024;149(19):4770\u201388.","journal-title":"ACS Sens"},{"key":"2893_CR76","doi-asserted-by":"publisher","unstructured":"Vairaperumal T, Lee PT, Liu PY. Portable point-of-care diagnosis platforms and emergingpredictive biomarkers for rapid detection of severe dengue viral infection. ACS Sens.2025;10(5):3302\u201316. https:\/\/doi.org\/10.1021\/acssensors.5c00263","DOI":"10.1021\/acssensors.5c00263"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02893-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02893-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02893-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T20:32:19Z","timestamp":1757449939000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02893-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2893"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02893-6","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed and approved the final manuscript and consent to its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"295"}}